CTRI/2021/07/035042
Completed
未知
A two-arm prospective, randomized, double blind, active controlled comparative study of 2 Anti-Dandruff shampoos, in patients with dandruff or seborrheic dermatitis
upin Ltd0 sites89 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: L21- Seborrheic dermatitis
- Sponsor
- upin Ltd
- Enrollment
- 89
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •With clinical diagnosis of Dandruff or seborrheic dermatitis of the scalp.
Exclusion Criteria
- •Pregnancy by UPT or Lactating women
- •History or presence of compromising dermatosis elsewhere on the skin
- •Actinically damaged skin
- •Have used an antidandruff agent in the past 14 days
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A clinical trial to study the effects of two drugs, Dynapar QPS and placebo topical solution in patient suffering from osteoarthritis.Health Condition 1: null- Osteoarthritis of kneeCTRI/2015/02/005510Troikaa Pharmaceuticals Limited212
Not yet recruiting
Phase 4
A prospective,randomized,double-blind,2-arm,active-controlled,parallel,multicentre,postmarketingclinical trial to assesstheefficacy andsafety ofRabeprazole SodiumEC Capsules20mg ascomparedtoconventionalRabeprazoleGastroResistantTablets IP20mg in patients with gastro-oesophageal reflux diseaseCTRI/2022/01/039744Zydus Healthcare Limited
Completed
Phase 2
Clinical study to evaluate and compare the immunogenicity and safety of Tetanus vaccine of Cadila Healthcare Ltd. vs Tetanus vaccine of Serum Institute of India Ltd. in healthy subjects and subjects with clean minor woundsCTRI/2015/05/005740Cadila Healthcare Ltd283
Recruiting
Phase 2
Clinical study to compare the immune response and safety of trivalent flu vaccine manufactured by Cadila Healthcare Ltd. with a trivalent flu vaccine marketed in India in healthy adultsHealth Condition 1: Z23- Encounter for immunizationCTRI/2015/09/006208Cadila Healthcare Ltd348
Recruiting
Phase 2
Clinical study to compare the immune response and safety of tetravalent flu vaccine manufactured by Cadila Healthcare Ltd. with a trivalent flu vaccine marketed in India in healthy adultsHealth Condition 1: Z23- Encounter for immunizationCTRI/2015/09/006209Cadila Healthcare Ltd348